Tetra Bio Pharma Inc TBPMQ

Healthcare Cannabis

Tetra Bio-Pharma Inc. is a Canada-based cannabinoid-derived drug discovery and development company. The Company has developed a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. The Company has a pipeline of formulations and drug delivery systems with a portfolio of assets from the early research and development phase to advanced stage clinical programs. Its products include QIXLEEF, CAUMZ, PPP004, REDUVO, and REBORN 1. QIXLEEF is a botanical therapy with a fixed dosage of tetrahydrocannabinol (THC) and cannabidiol (CBD). CAUMZ is its inhaled cannabinoid-derived drug candidate. PPP004 is a topical preparation containing either a standardized amount of CBD or a defined ratio of THC and CBD. REDUVO is a soft gel capsule used to treat chemotherapy-induced nausea and vomiting (CINV) and weight loss and severe nausea in people living with human immunodeficiency virus (HIV) infection. REBORN 1 is in phase II trial.

GREY:TBPMQ - Post by User

Tetra Bio Pharma Inc > Reduvo and health Canada

<< Previous

Bullboard Posts

Next >>

Post by Golddetectoron Feb 12, 2023 5:11pm

679 Views

Post# 35282269

Reduvo and health Canada

It is almost 2 months since last update. Are we getting any meaningful updates from Tbp? It is more than 2 years now since initial submission. How much longer we have to wait. It is getting frustrating here. Sp is at the level that there is No point of looking at it.

<< Previous

Bullboard Posts

Next >>

Changing Europe’s dependency on HREE from China